» Articles » PMID: 36780019

The Impact of Diabetes Mellitus on Pelvic Organ Prolapse Recurrence After Robotic Sacrocolpopexy

Overview
Publisher Springer
Date 2023 Feb 13
PMID 36780019
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction And Hypothesis: Data examining the effect of diabetes mellitus (DM) on prolapse recurrence after sacrocolpopexy (SCP) is limited. The primary objective of this study was to determine if DM affects prolapse recurrence after robotic SCP.

Methods: This was a retrospective cohort study of women who underwent robotic SCP between 2012 and 2019 at Kaiser Permanente Southern California. The cohort was divided into women with and without DM at the time of SCP. The primary outcome was composite failure. Secondary outcomes included recurrent compartment-specific prolapse, reoperation rates, and surgical complications.

Results: Of 547 patients included, 100 had DM. Women with DM were older, had higher BMI, higher parity, and were more likely to be nonwhite. Women with DM had more advanced prolapse at baseline but were not more likely to undergo concomitant procedures at the time of SCP. Over a median follow-up of 2.1 years (IQR 1.3, 3.4), women with DM had significantly increased risk of anterior vaginal prolapse (AVP) recurrence (13% vs 3%, p<0.01), but not composite failure (21% vs 14%, p=0.14). On multivariate regression, women with DM were almost 4 times as likely to experience AVP recurrence over time (AVP hazard ratio (HR) 3.93, 95% CI 1.29-12.03, p=0.02).

Conclusion: In our cohort, DM was a risk factor for AVP recurrence but not composite failure after robotic SCP.

Citing Articles

Composite Failure Associated With Sacrohysteropexy and Sacrocolpopexy With Supracervical Hysterectomy for Advanced Pelvic Organ Prolapse.

Sato H, Otsuka S, Sugita K, Abe H, Tsukada S Neurourol Urodyn. 2024; 44(2):434-442.

PMID: 39704264 PMC: 11788943. DOI: 10.1002/nau.25640.


Expression of insulin-like growth factor binding protein 5 in the vaginal wall tissues of older women with pelvic organ prolapse.

Duan Y, Chen Y, He Y, Gong R, Xia Z Sci Rep. 2024; 14(1):18353.

PMID: 39112783 PMC: 11306330. DOI: 10.1038/s41598-024-69098-9.


The Outcome of Sacrocolpopexy/Sacrohysteropexy for Patients with Pelvic Organ Prolapse and Predictors of Anatomical Failure.

Alsahabi J, AlSary S, Abolfotouh M Int J Womens Health. 2023; 15:1093-1105.

PMID: 37483888 PMC: 10362893. DOI: 10.2147/IJWH.S413729.

References
1.
Swift S, Woodman P, OBoyle A, Kahn M, Valley M, Bland D . Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005; 192(3):795-806. DOI: 10.1016/j.ajog.2004.10.602. View

2.
Nygaard I, Bradley C, Brandt D . Pelvic organ prolapse in older women: prevalence and risk factors. Obstet Gynecol. 2004; 104(3):489-97. DOI: 10.1097/01.AOG.0000136100.10818.d8. View

3.
Whitcomb E, Rortveit G, Brown J, Creasman J, Thom D, Van Den Eeden S . Racial differences in pelvic organ prolapse. Obstet Gynecol. 2009; 114(6):1271-1277. PMC: 2879888. DOI: 10.1097/AOG.0b013e3181bf9cc8. View

4.
Kudish B, Iglesia C, Gutman R, Sokol A, Rodgers A, Gass M . Risk factors for prolapse development in white, black, and Hispanic women. Female Pelvic Med Reconstr Surg. 2012; 17(2):80-90. PMC: 4354733. DOI: 10.1097/SPV.0b013e31820e5d06. View

5.
Smith F, Holman C, Moorin R, Tsokos N . Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010; 116(5):1096-100. DOI: 10.1097/AOG.0b013e3181f73729. View